Live feed
Filing
SC 13G/A
SC 13G/A0001104659-24-023890·Lyra Therapeutics, Inc.
Schedule 13G ownership disclosure
LYRA THERAPEUTICS INC
Security class unavailable · CUSIP: 55234L105
Event date: 2023-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,752,324
- Percent of class
- 8.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-023890
- Form type
- SC 13G/A
- Filer
- Lyra Therapeutics, Inc.
- CIK
- CIK 1327273
- Filed
- Feb 14, 2024
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership